首页> 中文期刊>中国医药指南 >云南白药联合酚妥拉明治疗支气管扩张咯血的临床分析

云南白药联合酚妥拉明治疗支气管扩张咯血的临床分析

     

摘要

目的:探讨云南白药联合酚妥拉明治疗支气管扩张咯血的临床疗效。方法90例支气管扩张咯血患者,分成观察组和对照组。对照组给予酚妥拉明治疗。观察组给予云南白药联合酚妥拉明治疗。结果观察组总有效率97.78%高于对照组82.22%,差异有统计学意义(P<0.05)。结论云南白药联合酚妥拉明治疗支气管扩张咯血患者疗效佳,建议临床推广应用。%Objective To discuss the clinical effect of Yunnan Baiyao combined with phentolamine in treatment of bronchiectasis hemoptysis. Method 90 cases of bronchiectasis hemoptysis patients, divided into the observation group and the control group. The control group was treated with phentolamine treatment. The observation group was given Yunnan Baiyao combined with phentolamine treatment. Results The observation group the total effective rate was 97.78%higher than 82.22%in the control group, the difference was statistically signiifcant (P<0.05). Conclusion Yunnan Baiyao combined with phentolamine in treating bronchiectasis hemoptysis of patients with good effect, recommended for clinical application.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号